New clinical trial for NET patients. This trial is not yet open for recruitment, but should be in the near future. Here is some basic information:
Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy. Here’s the Mayo link http://www.mayo.edu/research/clinical-trials/cls-20337811
And here’s the listing on clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT02705313
Mayo has only a limited number of slots. Jennifer Pickett is the study coordinator who works with this trial.
When this opens for recruitment, I will let you know.
@amyh2439 @tresjur @joannem @gaylejean @lucci50 @derekd @gulzar @joanney @jenchaney727 @dzerfas @lorettanebraska@wordnoid @trouble and @upblueeyes @ahtaylor @heidilynn4 @junebug15 @tomewilson @gman007 @mollie59 @amani79 @collielady@somefan @debf
Liked by John, Volunteer Mentor